Why the Dow is being dragged down by a Swiss company’s bad news


Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top